Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Nature Communications
|
July 2, 2024
Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals
Chengjie Xiong, Jingqin Luo, David A Wolk, et al.
Brain Communications
|
March 20, 2024
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease
Karin L Meeker, Patrick H Luckett, Nicolas R Barthélemy, et al.
Science Advances
|
April 3, 2024
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
Francis Shue, Launia J White, Rachel Hendrix, et al.
Annals of Neurology
|
February 24, 2024
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset
Yan Li, Daniel Yen, Rachel D Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
Suzanne E Schindler, Yan Li, Kaitlin W Todd, et al.
The Lancet. Neurology
|
December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study
Anna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Cell Biochemistry and Biophysics
|
February 26, 2004
Adult reserve stem cells and their potential for tissue engineering
Henry E Young, Cecile Duplaa, Marina Romero-Ramos, et al.
Annals of Neurology
|
December 1, 2023
Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals
Samuele Bonomi, Ruijin Lu, Suzanne E Schindler, et al.
Journal of Cellular and Molecular Medicine
|
October 6, 2005
Adult-derived stem cells and their potential for use in tissue repair and molecular medicine
Henry E Young, Cecile Duplaa, Ryan Katz, et al.
The Lancet. Neurology
|
July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study
Anne M Fagan, Rachel L Henson, Yan Li, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Nature Communications
|
July 2, 2024
Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals
Chengjie Xiong, Jingqin Luo, David A Wolk, et al.
Brain Communications
|
March 20, 2024
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease
Karin L Meeker, Patrick H Luckett, Nicolas R Barthélemy, et al.
Science Advances
|
April 3, 2024
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
Francis Shue, Launia J White, Rachel Hendrix, et al.
Annals of Neurology
|
February 24, 2024
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset
Yan Li, Daniel Yen, Rachel D Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
Suzanne E Schindler, Yan Li, Kaitlin W Todd, et al.
The Lancet. Neurology
|
December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study
Anna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Cell Biochemistry and Biophysics
|
February 26, 2004
Adult reserve stem cells and their potential for tissue engineering
Henry E Young, Cecile Duplaa, Marina Romero-Ramos, et al.
Annals of Neurology
|
December 1, 2023
Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals
Samuele Bonomi, Ruijin Lu, Suzanne E Schindler, et al.
Journal of Cellular and Molecular Medicine
|
October 6, 2005
Adult-derived stem cells and their potential for use in tissue repair and molecular medicine
Henry E Young, Cecile Duplaa, Ryan Katz, et al.
The Lancet. Neurology
|
July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study
Anne M Fagan, Rachel L Henson, Yan Li, et al.
Page
of 8